For Veterans, Psychedelic Access Must Mean More Than Access To A Drug (Op-Ed)
Veterans' advocacy highlights why psychedelic access requires structured therapeutic support, offering key lessons for c…
Read more →Canopy enters UK medical cannabis market with distribution deal
Canopy Growth enters the UK medical cannabis market by partnering with GROW Group to supply four Canadian-grown flower s…
Read more →
Medical Marijuana Improves Lower Back Back Pain And Reduces Opioid Use, New 10-Year Study Shows
New 10-year study shows medical marijuana reduces lower back pain and opioid use. Key insights for cannabis dispensaries…
Read more →
10-Year Study: Back Pain Patients Report Sustained Improvements, Decreased Reliance on Pharmaceuticals Following Medical Cannabis Treatment
A 10-year study shows medical cannabis reduces opioid use by 89.8% and lowers back pain intensity. See what this means f…
Read more →
Medical Marijuana Helps Cancer Patients With Pain, Anxiety And Nausea, Government Study Shows
New Minnesota government study reveals medical marijuana significantly reduces cancer patient pain, anxiety, and nausea …
Read more →
FDA Officials Lay Out Plan To Make Psychedelic Therapies Available To Patients ‘More Quickly’
FDA outlines a new framework to accelerate psychedelic drug approvals, signaling broader federal shifts toward alternati…
Read more →
There Will Be ‘Enormous Demand’ For Psychedelic Treatments, RFK Says, Praising Trump’s Action On The Issue
HHS Secretary RFK Jr. predicts massive demand for psychedelic therapies under Trump, signaling potential shifts for the …
Read more →
CBD Helps Athletes Recover From Exercise But Does Not Boost Performance, Study Shows
New study shows CBD aids athletic recovery and reduces muscle soreness without boosting performance, offering targeted m…
Read more →Why a cannabis business is betting on dogs to reach FDA approval
Endovia pursues FDA veterinary approval for cannabinoid drugs targeting canine cancer and chronic pain, seeking mainstre…
Read more →
Marijuana Improves Symptoms For People With Anorexia And Other Eating Disorders, Study Finds
New study shows cannabis improves symptoms for restrictive eating disorders like anorexia. Learn what this means for can…
Read more →
Integrating Medical Cannabis Into Dentistry Can Boost Patient Quality Of Life During Treatments, Study Finds
New scientific study highlights medical cannabis potential in dentistry for treating orofacial pain and periodontal dise…
Read more →
Newly Released VA Records Raise Questions About How ‘Cannabis Use Disorder’ Diagnoses Are Affecting Veterans (Op-Ed)
Newly released VA records raise questions about how Cannabis Use Disorder diagnoses impact veterans using medical cannab…
Read more →
Cannabis Has ‘Therapeutic Promise’ For People With Restless Leg Syndrome, Scientific Review Concludes
New scientific review highlights cannabis and CBD as therapeutic options for restless leg syndrome, signaling new opport…
Read more →
High Doses Of THC From Cannabis Can Produce ‘Psychedelic-Like States,’ Study Shows
New study shows high doses of THC produce psychedelic-like states similar to psilocybin, offering potential implications…
Read more →
Federally Funded Cancer Study Highlights Need To Cover Medical Marijuana Under Insurance, Researchers Say
New federally funded study highlights high costs of medical cannabis for cancer patients, fueling calls for health insur…
Read more →
Study: Oregon Psilocybin Program Provides Sustained Benefits
OHSU study shows Oregon psilocybin program delivers sustained mental health benefits, signaling growth for regulated alt…
Read more →
Alabama’s Second Medical Marijuana Dispensary Opens
Alabama's second medical cannabis dispensary opens in Talladega, marking a slow but steady expansion of patient access a…
Read more →Medical Cannabis Reduces Pain, Insomnia Or Mood Issues In 91% Of Older Adults, Study Finds
New study shows 91% of older adults find relief from pain and insomnia using medical cannabis, signaling new opportuniti…
Read more →About Medical Cannabis News
Medical cannabis research is accelerating as legal access expands and scientific interest grows. Peer-reviewed studies are examining cannabis and cannabinoids for pain management, anxiety, PTSD, epilepsy, cancer symptom relief, and dozens of other conditions. Clinical trial results, FDA decisions on cannabis-derived pharmaceuticals, and state medical program expansions all shape the medical cannabis market and the patients who depend on it. For dispensaries with medical programs, staying current on research helps staff educate patients and positions the brand as a trusted healthcare resource.
State medical cannabis programs continue to evolve — adding qualifying conditions, adjusting possession limits, and transitioning to or from adult-use frameworks. Healthcare provider attitudes toward cannabis recommendations are also shifting, with more physicians willing to discuss cannabis as an adjunct therapy. Medical dispensaries face unique compliance requirements around patient data, labeling, and product testing that differ from adult-use retail operations.
This section covers the latest medical cannabis studies, state program updates, patient access developments, and pharmaceutical cannabis research. Cannabis Promotions provides context on what each development means for medical dispensaries and the patients they serve.